Basal Ganglia Perivascular Spaces Predict Long-Term Executive and Visuospatial Decline

Perivascular Spaces as Indicators of Microvascular Cognitive Risk

Cerebral small vessel disease is a leading vascular contributor to dementia, often identified through imaging markers like white matter hyperintensities and lacunes [1, 2]. While these markers are well-established predictors of cognitive impairment, the clinical significance of magnetic resonance imaging-visible perivascular spaces, which are fluid-filled cavities surrounding small cerebral vessels, has remained less clear [3, 4]. Historically, these spaces were often overlooked or considered incidental, yet evidence suggests they may reflect underlying endothelial dysfunction and impaired waste clearance [5, 6]. As the prevalence of small vessel disease rises globally with aging populations, understanding the independent prognostic value of each imaging feature is essential for accurate risk assessment [7]. A longitudinal analysis now clarifies how these specific vascular markers correlate with cognitive trajectories over a decade of follow-up, offering clinicians a more precise tool for evaluating dementia risk.

Longitudinal Cohort and Deep Learning Volumetrics

The researchers drew their data from the Vanderbilt Memory and Aging Project, a longitudinal observational cohort study based in Nashville, Tennessee. To ensure the findings reflected the early progression of vascular-related cognitive changes, the study included 750 participants who were free of stroke and dementia at the time of enrollment. This cohort had a mean age of 68 ± 9 years and was 52% female. At the start of the study, each participant underwent 3T magnetic resonance imaging to establish a baseline of cerebral small vessel disease burden. This imaging protocol allowed the team to quantify several distinct markers of vascular injury, including white matter hyperintensities volume, lacune counts (small, deep infarcts), and cerebral microbleeds counts. To achieve high precision in measuring perivascular spaces, the researchers utilized a deep learning algorithm (an automated computational model trained on large datasets to recognize and measure specific anatomical structures) to segment and calculate the perivascular space volume fraction. This automated approach provided a standardized volumetric assessment of these fluid-filled channels. Following the initial imaging, participants underwent comprehensive serial neuropsychological testing to track cognitive performance over an 11-year follow-up period. While the study spanned over a decade, the mean follow-up duration for the participants was 4.9 ± 3.1 years, providing a robust longitudinal dataset to evaluate how baseline vascular markers influenced the rate of cognitive decline in specific domains such as executive function and visuospatial skills.

Mapping the Association Between PVS and Cognitive Domains

To determine the specific impact of perivascular spaces on cognitive health, the researchers utilized linear mixed-effects models (statistical tools designed to analyze longitudinal data while accounting for both individual variability and fixed clinical factors). These models were rigorously adjusted for age, sex, race/ethnicity, and education level to isolate the effect of vascular markers. Furthermore, the analysis controlled for baseline cognitive status, the presence of the apolipoprotein E-ε4 allele (a genetic variant strongly associated with an increased risk for Alzheimer's disease), the Framingham Stroke Risk Profile (a weighted score used to predict an individual's 10-year probability of stroke), and total intracranial volume. This comprehensive adjustment ensures that the observed associations are not merely reflections of general aging or established genetic and cardiovascular risk factors. The analysis demonstrated that a higher basal ganglia perivascular space burden at baseline was associated with significantly worse longitudinal performance across several specific neuropsychological assessments. In tasks measuring language and semantic retrieval, higher burden correlated with declines in the Boston Naming Test (β = -29.63; 95% CI -56.66 to -2.60) and Animal Naming (β = -33.09; 95% CI -65.66 to -0.51). Processing speed and executive control also showed measurable deterioration, as evidenced by declining scores on the Wechsler Adult Intelligence Scale IV Coding task (β = -86.36; 95% CI -150.9 to -21.82), a test requiring the rapid transcription of symbols based on a digit key. Beyond individual test scores, the researchers identified a clear link between baseline imaging markers and broader cognitive decline. Higher basal ganglia perivascular space burden was associated with worse longitudinal performance in an executive function composite score (β = -9.51; 95% CI -14.33 to -4.68), which represents a combined measure of planning, working memory, and cognitive flexibility. The study also found that these vascular markers predicted a decline in an episodic memory composite score (β = -7.05; 95% CI -11.9 to -2.21), indicating that the presence of these fluid-filled spaces in the deep gray matter may serve as a precursor to widespread cognitive deterioration in aging populations.

Independent Prognostic Value in Head-to-Head Comparisons

Because markers of small vessel disease, such as white matter hyperintensities, lacunes, and microbleeds, often coexist in the aging brain, clinicians frequently face challenges in isolating their independent contributions to specific cognitive domains. While previous cross-sectional data indicated that perivascular spaces in the basal ganglia contribute to worse cognition independent of other vascular markers, this study provides longitudinal evidence of their prognostic value. Specifically, the researchers found that a higher basal ganglia perivascular space burden was associated with significantly worse longitudinal performance in the Hooper Visual Organization Test (β = -26.06; 95% CI -50.53 to -1.59), a tool used to assess visuospatial integration. To determine if these findings were merely a reflection of other co-occurring vascular pathologies, the authors conducted head-to-head comparisons that simultaneously tested multiple statistically significant markers of small vessel disease. In these rigorous models, basal ganglia perivascular space burden remained independently associated with the executive function composite (β = -7.47; 95% CI -12.84 to -2.10) and the Hooper Visual Organization Test (β = -22.11; 95% CI -42.38 to -1.85). These results demonstrate that basal ganglia perivascular space burden independently contributes to worse longitudinal executive function and visuospatial skills, regardless of the presence of white matter hyperintensities or lacunes. For the practicing physician, these findings support the role of perivascular spaces as a unique vascular contributor to the deep brain structure damage that underlies cognitive decline over time. By identifying perivascular spaces as an emerging marker of domain-specific cognitive deterioration, clinicians may eventually be able to use routine magnetic resonance imaging to better stratify dementia risk and tailor early interventions for aging patients.

References

1. Lam BYK, Cai Y, Akinyemi R, et al. The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis.. International journal of stroke : official journal of the International Stroke Society. 2023. doi:10.1177/17474930221137019

2. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010. doi:10.1136/bmj.c3666

3. Phelps J, Singh M, McCreary CR, et al. Cerebral small vessel disease lesion segmentation methods: A systematic review.. Cerebral circulation - cognition and behavior. 2025. doi:10.1016/j.cccb.2025.100396

4. Wu Q, Zhang J, Lei P, Zhu X, Huang C. Imaging markers of cerebral small vessel disease are associated with Alzheimer's disease: a systematic review and meta-analysis.. Frontiers in aging neuroscience. 2025. doi:10.3389/fnagi.2025.1498636

5. Yang S, Webb AJS. Associations between neurovascular coupling and cerebral small vessel disease: A systematic review and meta-analysis.. European stroke journal. 2023. doi:10.1177/23969873231196981

6. Low A, Mak E, Rowe JB, Markus HS, O'Brien JT. Inflammation and cerebral small vessel disease: A systematic review.. Ageing research reviews. 2019. doi:10.1016/j.arr.2019.100916

7. Rensma SP, Sloten TTV, Launer LJ, Stehouwer CDA. Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysis.. Neuroscience and biobehavioral reviews. 2018. doi:10.1016/j.neubiorev.2018.04.003